For Immediate Release

3D BioFibR Raises $3.52M toBring its Premium Collagen Fiber Products to Market
July 20, 2023 – HALIFAX, Nova Scotia - 3D BioFibR, a leading innovator in biomaterials for tissue
engineering, announced today it has raised over $3.52M in seed financing. The financing will be used toexpand 3D BioFibR’s facilities to include a climate controlled biomanufacturing cleanroom and bring its
premium collagen fiber products to market.
“We are grateful for this investment as it accelerates our plan to meet the increasing demand fromtissue engineers for a premium 3D collagen scaffold that optimizes cell growth,” said Kevin Sullivan, CEOof 3D BioFibR. “Our goal is to make it incredibly easy for researchers to grow their cells in environmentsthat actually resemble human tissues.”
This financing round was led by Invest Nova Scotia with matching investment from Build Ventures andwith investment from returning investors Concrete Ventures and Globalive Capital.
The Government of Canada, through the Atlantic Canada Opportunities Agency (ACOA), is supporting
the project through a repayable $528,920 contribution to help create a new wet lab and cell culture
facility. The funding is being provided through ACOA’s Regional Economic Growth through Innovation(REGI) program. In addition, 3D BioFibR is receiving advisory services and research and development
funding of up to $391,949 from the National Research Council of Canada Industrial Research Assistance
Program (NRC IRAP) supporting the development of its automated collagen fiber manufacturing system.
“We see great market potential for 3D BioFibR’s premium collagen products for use in 3D cell cultureand tissue engineering applications,” said Patrick Keefe, general partner of Build Ventures. “We areexcited by the speed and skill with which they are building out their manufacturing capabilities.”
3D BioFibR’s fully automated and proprietary dry spinning process is the only process that produces highquality, diameter-controlled collagen fibers at commercial scale. The tissue engineering market is valued
at $26B and is growing at 35% compound annual growth.
“3D BioFibR’s best-in-class collagen fibers have the potential to make them a dominant player in thecellular scaffolds segment of the tissue engineering market,” said Dr. Lidija Marusic, interim vicepresident of investment at Invest Nova Scotia. “We’re pleased to continue to back the team behind sucha novel platform technology with many future applications.”“3D BioFibR is building a reputation for employing cutting-edge innovation to make impressive
biomedical advances,” said Andy Fillmore, Parliamentary Secretary to the Minister of Innovation,
Science and Industry and Member of Parliament for Halifax, on behalf of the Honourable Ginette
Petitpas Taylor, Minister of Official Languages and Minister responsible for ACOA. “The Government of
Canada is committed to helping Atlantic entrepreneurs like 3D BioFibR scale-up because when local
businesses succeed, they create jobs and solutions that benefit all Canadians.”
About CollagenIn the human body, collagen plays a crucial role as the primary structural element of the extracellularmatrix. This matrix forms a supportive framework for tissues, holding them together and imparting
3D BioFibR Inc. | © 2023

For Immediate Release-moremechanical durability. Collagen constitutes around 30% of the total protein content in the body.
Although collagen has widespread application in the biomedical field, researchers and clinicians typicallyutilize digested collagen in its monomeric form (individual proteins). While monomeric collagen serves
many valuable functions, there has been a persistent effort, for over five decades, to reassemble these
individual proteins into fibers that closely resemble natural collagen fibers found in the body, in terms ofappearance, structure, and function.
About 3D BioFibR Inc.
3D BioFibR produces high value collagen fibers at commercial scales for a variety of tissue engineeringand medical applications. The Company’s proprietary dry-spinning process produces fibers that are bestin-class from a strength, diameter, and quality perspective, recreating the natural appearance, structure,and function of collagen fibers. This manufacturing process is at least 3,600x faster than competing
manufacturing processes, making its collagen fibers accessible for an increasing number of biomedical
applications in the growing tissue engineering market. For more information, visit www.3DBioFibR.com.
This news release contains “forward-looking statements”, which reflect the current expectations of theCompany’s management for future growth, results of operations, performance, and business prospects.
Forward-looking statements involve significant known and unknown risks, uncertainties, andassumptions.
Contacts
INVESTOR RELATIONSKevin Sullivan, CEO
3D BioFibR Inc.
E: Info@3DBioFibR.com
W: www.3DBioFibR.com
MEDIA
Jennifer Cameron
Communications Advisor
E: jennifercameronpr@gmail.com
T: 902-209-4704

3D BioFibR Inc. | © 2023